Sunshine Biopharma Inc. has completed additional studies on orthotopic human tumor models in mice confirming its K1.1 mRNA lipid nanoparticle (K1.1-mRNA-LNP) product as a novel therapeutic agent for ...

Following encapsulation in two specifically designed Lipid Nanoparticles, the resulting K1.1c-mRNA-LNP and K1.1d-mRNA-LNP were efficiently delivered to orthotopic engrafted HCC tumors in mice in a ...

The lab examines how gender-specific factors influence bladder cancer development and progression, potentially uncovering unique aspects of the disease in different sexes. To achieve their research ...

This strategy integrates systemic administration to target metastatic progression with intratumoral administration to focus on primary tumors ... clinically relevant orthotopic models of ...